Hi everyone.
On 07/02/2023, our system had provided a few picks and the results are as below:
MRNA – (Sell) – Profit
BP – (Sell) – Withdrawn
TENX – (Buy) – In the market
The Dow finished more than 260 points higher after it pared 250 points losses during the session. Meanwhile, the S&P 500 and Nasdaq 100 gained 0.6% and 0.9%, respectively, as investors digest Fed Chair Jerome Powell’s remarks at the Economic Club of Washington.
Let’s review our stock picks on Tuesday.
A call for sell for MRNA which resulted in profit. Our system entered the market at $169.73 and made a call to profit at $167.95, which is our trailing stop loss.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines.
A call for sell for BP which was withdrawn because the price opened with a gap above our EP and continued upwards throughout the market.
BP p.l.c. engages in the energy business worldwide. It operates through Gas & Low Carbon Energy, Oil Production & Operations, Customers & Products, and Rosneft segments. It produces and trades in natural gas; offers biofuels; operates onshore and offshore wind power, and solar power generating facilities; and provides de-carbonization solutions and services, such as hydrogen and carbon capture and storage. The company is also involved in the convenience and mobility business, which manages the sale of fuels to retail customers, convenience products, aviation fuels, and Castrol lubricants; and refining and trading of oil products, as well as operation of electric vehicle charging facilities.
A call for buy for TENX which is still in the market. Our system picked this stock as a swing trade and it is currently trading at a loss in the market. Follow this stock for all status updates.
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension.
Stay tuned for more of our stock picks.
Want the next pick before it's written up?
AIRESCAN's AI publishes live recommendations in the app.